KAS
KYNB

Kestra Advisory Services’s Kyntra Bio KYNB Stock Holding History

Kestra Advisory Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-506
Closed -$6.7K – 2807
2024
Q4 		$6.7K Hold
506
– – ﹤0.01% 2644
2024
Q3 		$5.05K Hold
506
– – ﹤0.01% 2545
2024
Q2 		$11.3K Hold
506
– – ﹤0.01% 2604
2024
Q1 		$29.7K Hold
506
– – ﹤0.01% 2419
2023
Q4 		$11.2K Hold
506
– – ﹤0.01% 2257
2023
Q3 		$10.9K Hold
506
– – ﹤0.01% 2096
2023
Q2 		$34.1K Hold
506
– – ﹤0.01% 2060
2023
Q1 		$236K Sell
506
-13
-3% -$6.88K ﹤0.01% 1723
2022
Q4 		$208K Buy
519
+12
+2% +$4.6K ﹤0.01% 2001
2022
Q3 		$165K Buy
507
+1
+0.2% +$322 ﹤0.01% 1908
2022
Q2 		$134K Sell
506
-32
-6% -$8.18K ﹤0.01% 1951
2022
Q1 		$162K Buy
538
+60
+13% +$20.9K ﹤0.01% 1890
2021
Q4 		$168K Sell
478
-120
-20% -$37.4K ﹤0.01% 1900
2021
Q3 		$153K Sell
598
-260
-30% -$92.1K ﹤0.01% 2015
2021
Q2 		$571K Buy
858
+409
+91% +$236K 0.01% 1221
2021
Q1 		$389K Sell
449
-15
-3% -$16K ﹤0.01% 1314
2020
Q4 		$440K Buy
+464
New +$488K 0.01% 1272

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kestra Advisory Services's KYNB Position: Q1 2025 in Review

Kestra Advisory Services sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 506 shares — an estimated $6.7K sold.

Kestra Advisory Services first reported a position in KYNB in Q4 2020 and held it in 17 quarters. The position peaked at $571K in Q2 2021. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Kestra Advisory Services reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Kestra Advisory Services sold 506 Kyntra Bio shares in Q1 2025, an estimated $6.7K.
  • Kestra Advisory Services first reported a position in Kyntra Bio in Q4 2020 and held it in 17 quarters.
  • Kestra Advisory Services's Kyntra Bio position peaked at $571K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Kestra Advisory Services's 13F filing for Q1 2025, filed 14 May 2025.